Results 261 to 270 of about 545,624 (314)
Some of the next articles are maybe not open access.
Nature Reviews Cancer, 2021
Gao, Xia, Li, Zhang et al. show that a circular RNA-encoded variant of E-Cadherin stimulates EGFR signalling independently of EGF, and contributes to glioblastoma tumorigenesis and anti-EGFR therapy resistance.
openaire +2 more sources
Gao, Xia, Li, Zhang et al. show that a circular RNA-encoded variant of E-Cadherin stimulates EGFR signalling independently of EGF, and contributes to glioblastoma tumorigenesis and anti-EGFR therapy resistance.
openaire +2 more sources
Clonal dominance of EGFR and efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC.
Journal of Clinical Oncology, 2020e21501 Background: Though EGFR mutations in lung cancer are identified most often on the trunks of tumor phylogenetic trees in early stage, whether EGFR would always be the dominant clone in the advanced stage is unknown, as cancer evolution often follows a branched trajectory, with divergent subclones evolving simultaneously.
Xinghao Ai +14 more
openaire +1 more source
European Journal of Cancer, 2001
Elevated levels of the epidermal growth factor receptor (EGFR), a growth-factor-receptor tyrosine kinase, and/or its cognate ligands have been identified as a common component of multiple cancer types and appear to promote solid tumour growth. This article examines the relationship between EGFR expression and cancer prognosis based on literature ...
R I, Nicholson, J M, Gee, M E, Harper
openaire +2 more sources
Elevated levels of the epidermal growth factor receptor (EGFR), a growth-factor-receptor tyrosine kinase, and/or its cognate ligands have been identified as a common component of multiple cancer types and appear to promote solid tumour growth. This article examines the relationship between EGFR expression and cancer prognosis based on literature ...
R I, Nicholson, J M, Gee, M E, Harper
openaire +2 more sources
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Science, 2004J. Paez +16 more
semanticscholar +1 more source
Overcoming therapy resistance in EGFR-mutant lung cancer
Nature Cancer, 2021A. Passaro, P. Jänne, T. Mok, S. Peters
semanticscholar +1 more source
EGFR activation limits the response of liver cancer to lenvatinib
Nature, 2021Haojie Jin +30 more
semanticscholar +1 more source
EGFR mutations and EGFR tyrosine kinase inhibitors
The Lancet Oncology, 2015Valter, Torri +2 more
openaire +2 more sources